KRAS and neoplasm: These included increased expression of known proto-oncogenes, such as Kras[9,10] and Rras[10], and the oncomiR microRNA-155 [11-13], as well as suppression of the expression of Socs1, a known tumor suppressor [14] (Figure 4A).